Lannett Recalls
15 recalls on record · October 31, 2018 to July 8, 2026 · Drugs
Recalls by year
18
19
20
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 8, 2026DrugsFDA
Lannett Company Inc. recalls Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Exten
Hazard: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
June 10, 2026DrugsFDA
Lannett Company Inc. recalls Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philad
Hazard: Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
May 27, 2026DrugsFDA
Lannett Company Inc. recalls Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136,
Hazard: Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
October 29, 2025DrugsFDA
Lannett Company Inc. recalls Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., P
Hazard: Failed Dissolution Specifications
September 17, 2025DrugsFDA
Lannett Company Inc. recalls Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 10
Hazard: Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.
September 3, 2025DrugsFDA
Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadel
Hazard: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
December 11, 2024DrugsFDA
Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelp
Hazard: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
January 25, 2023DrugsFDA
Lannett Company Inc. recalls Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distribu
Hazard: Failed Impurity/Degradation Specifications
January 25, 2023DrugsFDA
Lannett Company Inc. recalls Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: La
Hazard: Failed Impurity/Degradation Specifications
February 23, 2022DrugsFDA
Lannett Company, Inc. recalls Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only, Distributed by: Lanne
Hazard: Failed Impurities/Degradation Specifications: Out of specification results for related substances.
August 26, 2020DrugsFDA
Lannett Company, Inc. recalls Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, Ma
Hazard: Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg
December 25, 2019DrugsFDA
Lannett Company, Inc. recalls Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Distributed by: Lannett Company, Inc. Philad
Hazard: Microbial Contamination of Non-sterile Products: Out-of-specification results obtained for Total Aerobic Microbial Count.
November 20, 2019DrugsFDA
Lannett Company, Inc. recalls Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distributed by: Lannett Company, Inc. Philade
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
March 20, 2019DrugsFDA
Lannett Company Inc. recalls Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Phi
Hazard: Failed Dissolution Specifications
October 31, 2018DrugsFDA
Lannett Company, Inc. recalls HydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx only, Distributed by
Hazard: CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.